About biote corp - BTMD
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.
BTMD At a Glance
biote Corp.
1875 West Walnut Hill Lane
Irving, Texas 75038
| Phone | 1-844-604-1246 | Revenue | 192.22M | |
| Industry | Hospital/Nursing Management | Net Income | 27.05M | |
| Sector | Health Services | Employees | 223 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
BTMD Valuation
| P/E Current | 5.244 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 3.525 |
| Price to Sales Ratio | 0.496 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 2.71 |
| Enterprise Value to EBITDA | 4.855 |
| Enterprise Value to Sales | 1.081 |
| Total Debt to Enterprise Value | 0.618 |
BTMD Efficiency
| Revenue/Employee | 861,968.61 |
| Income Per Employee | 121,278.027 |
| Receivables Turnover | 25.038 |
| Total Asset Turnover | 1.672 |
BTMD Liquidity
| Current Ratio | 1.215 |
| Quick Ratio | 0.784 |
| Cash Ratio | 0.536 |
BTMD Profitability
| Gross Margin | 69.759 |
| Operating Margin | 20.353 |
| Pretax Margin | 19.553 |
| Net Margin | 14.07 |
| Return on Assets | 23.519 |
| Return on Equity | N/A |
| Return on Total Capital | 38.70 |
| Return on Invested Capital | 62.171 |
BTMD Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 183.767 |
| Total Debt to Total Assets | 119.337 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 147.504 |